Browse Drug Recalls
17,897 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 17,897 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 17,897 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Sep 7, 2018 | Minivelle (estradiol transdermal system) Patches, Delivers 0.025 mg/day, 8 co... | Defective Delivery System: out of specification results for shear, an attribute related to the ad... | Class II | Noven Pharmaceuticals, Inc. |
| Sep 7, 2018 | Minivelle (estradiol transdermal system) Patches Delivers 0.1 mg/day, a) 2 co... | Defective Delivery System: out of specification results for shear, an attribute related to the ad... | Class II | Noven Pharmaceuticals, Inc. |
| Sep 7, 2018 | Minivelle (estradiol transdermal system) Patches, Delivers 0.075 mg/day, 8 co... | Defective Delivery System: out of specification results for shear, an attribute related to the ad... | Class II | Noven Pharmaceuticals, Inc. |
| Sep 6, 2018 | Bupropion Hydrochloride ER Tablets, USP 150 mg, packaged in a) 90-count bottl... | Failed impurities/ degradation specifications: Out-of-specification results were observed in the ... | Class III | InvaGen Pharmaceuticals, Inc. |
| Sep 6, 2018 | 0.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare ... | cGMP Deviation | Class II | Baxter Healthcare Corporation |
| Sep 6, 2018 | Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30... | Failed impurities/degradation specifications: Finished product contain a known product impurity a... | Class III | Par Pharmaceutical, Inc. |
| Sep 4, 2018 | Tizanidine HCl Tablets, USP 2mg, 150-count bottles, Rx Only, Mfd. By: Dr. Red... | Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl T... | Class II | Dr. Reddy's Laboratories, Inc. |
| Sep 4, 2018 | Synjardy (empagliflozin and metformin hydrochloride) Tablets. 5 mg/1000 mg. R... | Cross Contamination With Other Products: | Class II | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Aug 31, 2018 | NeoRelief for Muscle Cramping & Restlessness Homeopathic Topical Gel, package... | CGMP Deviations: finished product produced with active ingredients recalled by the manufacturer, ... | Class II | BioLyte Laboratories, LLC |
| Aug 31, 2018 | Skin Irritation & Itch Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) per ... | CGMP Deviations: products manufactured by contract manufacturer under conditions that could resul... | Class II | Beaumont Bio-med, Inc. |
| Aug 31, 2018 | Diarrhea Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass or... | CGMP Deviations: products manufactured by contract manufacturer under conditions that could resul... | Class II | Beaumont Bio-med, Inc. |
| Aug 31, 2018 | Allergy & Hay Fever Relief Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber... | CGMP Deviations: products manufactured by contract manufacturer under conditions that could resul... | Class II | Beaumont Bio-med, Inc. |
| Aug 31, 2018 | Sinus Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral ... | CGMP Deviations: products manufactured by contract manufacturer under conditions that could resul... | Class II | Beaumont Bio-med, Inc. |
| Aug 31, 2018 | Colds & Flu Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass... | CGMP Deviations: products manufactured by contract manufacturer under conditions that could resul... | Class II | Beaumont Bio-med, Inc. |
| Aug 31, 2018 | Arthritis Pain Relief Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glas... | CGMP Deviations: products manufactured by contract manufacturer under conditions that could resul... | Class II | Beaumont Bio-med, Inc. |
| Aug 31, 2018 | Muscle & Joint Pain Relief Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber... | CGMP Deviations: products manufactured by contract manufacturer under conditions that could resul... | Class II | Beaumont Bio-med, Inc. |
| Aug 31, 2018 | Sore Throat & Laryngitis Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) pe... | CGMP Deviations: products manufactured by contract manufacturer under conditions that could resul... | Class II | Beaumont Bio-med, Inc. |
| Aug 30, 2018 | Thyroid powder, 4.5 kg foil bag, 5x1 kg foil bags packed in 25 Kg Fiber Drum,... | CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels... | Class II | Alkano Chemicals, Inc |
| Aug 28, 2018 | Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grai... | CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels... | Class II | Humco Holding Group, Inc |
| Aug 28, 2018 | Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 2.5 mL Single-use Vial, Rx o... | Failed Impurities/Degradation Specifications; Out of specification stability testing results at t... | Class III | Pfizer Inc. |
| Aug 28, 2018 | Thyroid, USP (Full Strength) Levothyroxine 112.1 mcg/grain Liothyronine 29.2 ... | CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels... | Class II | Humco Holding Group, Inc |
| Aug 28, 2018 | Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grai... | CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels... | Class II | Humco Holding Group, Inc |
| Aug 27, 2018 | Furosemide 100 mg added to 0.9% Sodium Chloride 100 mL Injection, 100 mL Sing... | Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the... | Class I | SCA Pharmaceuticals, Inc. |
| Aug 27, 2018 | Norepinephrine 4 mg (16 mcg/mL) added to 5% Dextrose 250 mL Bag Preservative ... | Subpotent Drug: Product may not have the active ingredient present in the bag. | Class I | QuVa Pharma, Inc. |
| Aug 27, 2018 | MethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubil... | Failed Stability Specifications: An out-of-specification result was obtained during 18-month stab... | Class III | Jubilant Cadista Pharmaceuticals, Inc. |
| Aug 27, 2018 | Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, Rx Only, 3... | Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs. | Class III | Mylan Pharmaceuticals Inc. |
| Aug 24, 2018 | Thyroid Powder, USP, 25kg/drum, Rx Only, Sichuan Friendly Pharmaceutical Co.,... | CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine a... | Class II | LGM Pharma LLC |
| Aug 24, 2018 | Cortaid Intensive Therapy Cooling Spray (1% hydrocortisone), 2 FL OZ (59 mL) ... | CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products ... | Class II | Valeant Pharmaceuticals North America LLC |
| Aug 24, 2018 | Cortaid Maximum Strength Cream (1% hydrocortisone), 1 OZ (28 g) tube, OTC, Di... | CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products ... | Class II | Valeant Pharmaceuticals North America LLC |
| Aug 24, 2018 | Ethosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For... | Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified ... | Class II | Akorn, Inc. |
| Aug 24, 2018 | Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tablets, HDPE 90 cc bottles in c... | CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an act... | Class II | RemedyRepack Inc. |
| Aug 24, 2018 | Cortaid 12-Hour Advanced Anti-itch Cream (1% hydrocortisone), NET WT 1.5 oz. ... | CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products ... | Class II | Valeant Pharmaceuticals North America LLC |
| Aug 23, 2018 | Neuroveen, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: ... | Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, includ... | Class I | Hellolife |
| Aug 23, 2018 | Thyroveev, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: ... | Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, includ... | Class I | Hellolife |
| Aug 23, 2018 | Cefuroxime 10mg/mL INJ 0.5 mg, SDV, Rx only, Pacific Compounding, Stockton, CA | Presence of Particulate Matter: Particulate matter was reported in one lot of Cefuroxime by a phy... | Class II | Pacific Compounding Pharmacy & Consultations Inc |
| Aug 23, 2018 | Respitrol, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: ... | Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, includ... | Class I | Hellolife |
| Aug 23, 2018 | Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottle, Rx only, ... | Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being... | Class III | LUPIN SOMERSET |
| Aug 23, 2018 | Children s Advil Suspension Ibuprofen Oral Suspension, 100 mg per 5mL, 4 FL O... | Labeling Error: Not elsewhere classified. product has a dosage cup marked in teaspoons and the i... | Class II | Pfizer Global Supply |
| Aug 23, 2018 | Compulsin, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: ... | Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, includ... | Class I | Hellolife |
| Aug 22, 2018 | THYROID POWDER USP (Levothyroxine labeled range of 34.2-41.8mcg/grain; Liothy... | CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels... | Class II | Syntec Pharma Corp |
| Aug 22, 2018 | THYROID POWDER USP, Full Strength (Levothyroxine labeled range of 103-125mcg/... | CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels... | Class II | Syntec Pharma Corp |
| Aug 21, 2018 | Folic Acid injectable, 10 mg/ml, 30 ml Multiple Dose vial, Rx only, Central ... | Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... | Class II | Auro Pharmacies, Inc. |
| Aug 21, 2018 | Methyl-Cobalamin injectable, 10 mg/mL, 30 mL Multiple Dose vial, Rx only, Cen... | Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... | Class II | Auro Pharmacies, Inc. |
| Aug 21, 2018 | Calcium Gluconate injectable, 10%, 50 ml Single Dose vial, Rx only, Central D... | Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... | Class II | Auro Pharmacies, Inc. |
| Aug 21, 2018 | Methyl-Cobalamin injectable, 1 mg/mL, packaged in a) 5 mL and b) 30 mL Multi... | Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... | Class II | Auro Pharmacies, Inc. |
| Aug 21, 2018 | Oxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx ... | Labeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary cont... | Class III | Mayne Pharma Inc |
| Aug 21, 2018 | Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle, Rx Only, Manufact... | Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets US... | Class I | Accord Healthcare, Inc. |
| Aug 21, 2018 | 0.9% Sodium Chloride Injection USP 100 mL bags, Rx only, Baxter Healthcare Co... | CGMP Deviations | Class II | Baxter Healthcare Corporation |
| Aug 21, 2018 | Methyl-Cobalamin injectable, 5 mg/mL, 30 mL Multiple Dose vial, Rx only, Cent... | Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... | Class II | Auro Pharmacies, Inc. |
| Aug 21, 2018 | Testosterone Cypionate/Enanthate injectable, 200/50 mg/mL, packaged in a) 5 m... | Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... | Class II | Auro Pharmacies, Inc. |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.